• LAST PRICE
    2.3300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.2800/ 1
  • Ask / Lots
    2.6300/ 19
  • Open / Previous Close
    0.0000 / 2.3300
  • Day Range
    ---
  • 52 Week Range
    Low 1.7000
    High 8.1000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 2.3
TimeVolumeSCYX
09:32 ET27962.3
09:34 ET54002.26
09:41 ET2002.2971
09:43 ET2002.3
09:57 ET153002.23
09:59 ET29212.29
10:03 ET7002.29
10:06 ET1002.33
10:08 ET1302.335
10:10 ET10382.32
10:15 ET4292.32
10:17 ET7002.33
10:19 ET6002.33
10:21 ET2002.33
10:33 ET29662.33
10:35 ET6002.4
10:37 ET3962.38
10:39 ET23402.35
10:48 ET1002.37
10:53 ET1002.37
11:00 ET5382.37
11:06 ET1002.37
11:09 ET1002.37
11:13 ET72002.36
11:15 ET2502.38
11:18 ET2002.385
11:22 ET1002.4
11:24 ET1002.39
11:27 ET1002.4
11:29 ET18002.39
11:31 ET5002.37
11:36 ET13002.37
11:38 ET22002.35
11:44 ET9502.375
11:45 ET1002.39
11:51 ET1002.39
11:56 ET1002.39
12:02 ET1002.39
12:07 ET1002.39
12:14 ET24002.37
12:21 ET105082.38
12:23 ET2002.42
12:27 ET3002.41
12:30 ET5792.39
12:32 ET5002.41
12:34 ET1002.41
12:36 ET2502.4001
12:43 ET1002.43
12:52 ET2002.43
12:57 ET1002.43
12:59 ET1002.43
01:03 ET1002.43
01:10 ET7172.43
01:12 ET1002.45
01:14 ET2002.4101
01:15 ET2002.411
01:32 ET1002.43
01:39 ET4002.44
01:48 ET1002.44
01:51 ET1002.425
01:53 ET1002.425
01:57 ET1002.44
02:08 ET1002.44
02:15 ET2002.413
02:18 ET1002.43
02:27 ET1742.43
02:29 ET1002.43
02:31 ET1002.42
02:42 ET2502.4143
02:47 ET3002.41
02:58 ET9002.41
03:00 ET3502.411
03:03 ET29002.42
03:05 ET1002.42
03:07 ET3002.44
03:12 ET2502.4055
03:16 ET1002.43
03:36 ET113982.4
03:38 ET1002.39
03:39 ET16002.4
03:41 ET51682.43
03:43 ET4002.4
03:45 ET1002.4
03:48 ET7502.4
03:50 ET84202.39
03:52 ET54842.3901
03:54 ET105622.3811
03:56 ET124952.31
03:57 ET22002.38
03:59 ET125052.33
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSCYX
SCYNEXIS Inc
76.4M
-1.5x
---
United StatesGLS
Gelesis Holdings Inc
81.7M
0.0x
---
United StatesEYEN
Eyenovia Inc
65.3M
-3.6x
---
United StatesUG
United-Guardian Inc
56.6M
15.4x
+12.54%
United StatesHOOK
HOOKIPA Pharma Inc
79.3M
-0.7x
---
United StatesVRCA
Verrica Pharmaceuticals Inc
120.4M
-2.0x
---
As of 2022-09-29

Company Information

SCYNEXIS, Inc. is a biotechnology company. The Company is developing its lead product candidate, ibrexafungerp, as a broad-spectrum, intravenous (IV)/oral agent for multiple fungal indications in both the community and hospital settings. It has received the approval from the United States Food and Drug Administration (FDA) for the New Drug Application (NDA) for BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC, also known as vaginal yeast infection). BREXAFEMME is a triterpenoid antifungal indicated for the treatment of adult and postmenarchal pediatric females with vulvovaginal candidiasis (VVC). It is also continuing late-stage clinical development of ibrexafungerp for multiple indications, including the treatment of life-threatening invasive fungal infections in hospitalized patients.

Contact Information

Headquarters
1 Evertrust Plaza, 13Th FloorJERSEY CITY, NJ, United States 07302-6548
Phone
201-884-5485
Fax
919-544-8697

Executives

Non-Executive Independent Chairman of the Board
Guy Macdonald
Chief Executive Officer, Director
Marco Taglietti
Interim Chief Financial Officer
Lawrence Hoffman
Vice President - Clinical Development
Nkechi Azie
General Counsel
Scott Sukenick

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$76.4M
Revenue (TTM)
$3.1M
Shares Outstanding
32.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.92
EPS
$-1.58
Book Value
$1.44
P/E Ratio
-1.5x
Price/Sales (TTM)
24.5
Price/Cash Flow (TTM)
---
Operating Margin
-2,664.55%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.